Back to Journals » Therapeutics and Clinical Risk Management » Volume 14
Review
Ertugliflozin: a sodium-glucose cotransporter-2 (SGLT-2) inhibitor for glycemic control in type 2 diabetes
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
10,556 | Dovepress* | 9,369+ | 1,505 | 10,874 | |
PubMed Central* | 1,187 | 422 | 1,609 | ||
Totals | 10,556 | 1,927 | 12,483 | ||
*Since 7 September 2018 |
View citations on PubMed Central and Google Scholar